NS Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$8.58M Sell
351,170
-28,445
-7% -$652K 12.07% 2
2016
Q3
$9.56M Sell
379,615
-28,691
-7% -$687K 12.36% 2
2016
Q2
$8.43M Buy
408,306
+10,001
+3% +$208K 11.5% 2
2016
Q1
$8M Buy
398,305
+75,864
+24% +$1.45M 8.56% 3
2015
Q4
$6.52M Buy
322,441
+21,845
+7% +$460K 7.3% 6
2015
Q3
$6.97M Sell
300,596
-1,500
-0.5% -$38.3K 7.21% 5
2015
Q2
$7.78M Sell
302,096
-5,500
-2% -$156K 7.37% 5
2015
Q1
$10.2M Sell
307,596
-20,852
-6% -$677K 8.99% 2
2014
Q4
$9.97M Sell
328,448
-62,684
-16% -$1.73M 10.38% 2
2014
Q3
$9.51M Sell
391,132
-43,792
-10% -$1.21M 9.22% 2
2014
Q2
$12.5M Buy
434,924
+27,500
+7% +$799K 9.72% 2
2014
Q1
$11.4M Sell
407,424
-900
-0.2% -$24.7K 9.01% 3
2013
Q4
$10.7M Sell
408,324
-40,021
-9% -$1.03M 8.67% 5
2013
Q3
$10.3M Hold
448,345
7.61% 7
2013
Q2
$11.7M Buy
+448,345
New +$12.9M 7.98% 3

Other funds holding SBRA

NS Advisors's SBRA Position: Q4 2016 in Review

NS Advisors reduced its Sabra Healthcare REIT (SBRA) stake by 7.5% in Q4 2016, selling an estimated $652K and leaving 351,170 shares worth $8.58M. The position accounts for 12.07% of the portfolio, ranked #2.

NS Advisors first reported a position in SBRA in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.5M in Q2 2014. 198 funds tracked by Wall St. Rank hold SBRA as of Q4 2016.

  • NS Advisors held 351,170 shares of Sabra Healthcare REIT worth $8.58M as of Q4 2016.
  • NS Advisors sold 28,445 Sabra Healthcare REIT shares in Q4 2016, an estimated $652K.
  • Sabra Healthcare REIT made up 12.07% of NS Advisors's portfolio in Q4 2016, its #2 holding.
  • NS Advisors first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 15 quarters since.
  • NS Advisors's Sabra Healthcare REIT position peaked at $12.5M in Q2 2014.
  • 198 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2016.

Based on NS Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.